Free release
11-(1-Methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepine-3-carbaldehyde

11-(1-Methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepine-3-carbaldehyde

CAS No. :147084-10-4MDL No. :MFCD09954106Formula :C19H21N3OBoiling Point :-Linear Structure Formula :-InChI Key :MWTBKTR

Sales:Service@apichina.com
CAS No. :147084-10-4 Brand :Qitai
Formula :C19H21N3O M.W :307.39

Introduction

CAS No. :147084-10-4 MDL No. :MFCD09954106
Formula : C19H21N3O Boiling Point : -
Linear Structure Formula :- InChI Key :MWTBKTRZPHJQLH-UHFFFAOYSA-N
M.W : 307.39 Pubchem ID :19371515
Synonyms :
R89674;Lastacaft;trade name: Lastacaft
Chemical Name :11-(1-Methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepine-3-carbaldehyde

Physicochemical Properties

Num. heavy atoms : 23
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.37
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 95.04
TPSA : 38.13 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -7.0 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.55
Log Po/w (XLOGP3) : 1.66
Log Po/w (WLOGP) : 2.4
Log Po/w (MLOGP) : 1.8
Log Po/w (SILICOS-IT) : 3.12
Consensus Log Po/w : 2.3

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.08
Solubility : 0.256 mg/ml ; 0.000833 mol/l
Class : Soluble
Log S (Ali) : -2.07
Solubility : 2.59 mg/ml ; 0.00842 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.77
Solubility : 0.00518 mg/ml ; 0.0000169 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.39
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram: